,datetime,sentence,positive,negative,neutral,global_sentiment,avg_sentiment
0,2020-09-14 00:17:00,"For a live blog on European stocks, type LIVE/ in an Eikon news window

Sept 14 (Reuters) - UK shares rose on Monday as drugmaker AstraZeneca resumed trials of its COVID-19 vaccine, while Brexit fears simmered ahead of a parliament vote on a plan to break international law by breaching parts of the divorce treaty with the European Union.",0.1415814459323883,0.6919762492179871,0.16644230484962463,negative,-0.5503947734832764
1,2020-09-14 00:17:00,"The House of Commons will debate the Internal Market Bill, which the EU has demanded Prime Minister Boris Johnson scrap by the end of September.",0.1276625543832779,0.2673763036727905,0.604961097240448,neutral,-0.13971374928951263
2,2020-09-14 00:17:00,"After the debate, lawmakers will decide if it should go to the next stage.",0.0434061661362648,0.016104059293866158,0.9404897689819336,neutral,0.027302106842398643
3,2020-09-14 00:17:00,"The blue-chip FTSE 100 .FTSE rose 0.6% in early trading, with a 0.8% gain for AstraZeneca Plc AZN.L among the top boosts to the index.",0.9413979649543762,0.030346574261784554,0.028255540877580643,positive,0.9110513925552368
4,2020-09-14 00:17:00,"The drugmaker said over the weekend it had resumed British clinical trials of its COVID-19 vaccine, one of the most advanced in development, after getting the green light from safety watchdogs.",0.7784539461135864,0.06382068991661072,0.15772536396980286,positive,0.7146332263946533
